Purchase Order 15B41226P00000066
- Not listed
- The U.S. Federal Medical Center Rochester, a civilian federal medical facility operated by the Department of Justice Bureau of Prisons, awarded a $38,140.38 firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) on December 31, 2025. The contract, designated as B1 - PANTHERX - CRENESSITY, has no set-aside designation and extends through December 31, 2025, with performance to be executed in Pittsburgh, Pennsylvania. Pantherx Specialty...
- The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a $43,869.35 firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy and a subsidiary of Centene Corporation, for pharmacy services. The order is for Pantherx to provide pharmaceutical products and services to inmates at the Federal Medical Center Rochester facility in Pittsburgh, Pennsylvania from July 31, 2023 through August 4, 2023. As the Bureau of Prisons...
- This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Rochester, a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract, valued at $38,140.38, is for the delivery of specialized pharmaceutical products, such as TARPEYO (budesonide) 4mg capsules, Ruzurgi 10mg, and JOENJA, to support the medical needs of federal inmates. The contract has a performance period from August 21, 2025, to...
- The Federal Medical Center Rochester, a civilian facility under the Bureau of Prisons, awarded a delivery order to McKesson Corporation valued at $502,733.01 on December 1, 2025, with a completion date of December 31, 2025. This firm fixed-price delivery order, designated as FY26 B1 MCKESSON LD - PRIME VENDOR, procures pharmaceutical distribution and medical supply services from McKesson's Irving, Texas location. The award includes a funding modification (Modification 3) reflecting a decrease of...
- McKesson Corporation received a $12,331.63 firm fixed-price purchase order from the Federal Medical Center Rochester, a civilian facility within the Department of Justice, for pharmaceutical and medical supplies. This modification (Modification 2) provided a funding increase of $1,166.63 to the existing order, with the ultimate completion date of December 31, 2025. The contract, awarded on December 1, 2025, carries no small business set-aside designation and represents McKesson's continued...
- The Department of Justice's Bureau of Prisons awarded a firm fixed price delivery order contract to McKesson Corporation, a healthcare services and information technology company, to provide medications through the Prime Vendor Program at the Federal Medical Center in Rochester, Minnesota. The contract, which does not have a set-aside designation, has a potential value of $207,138.29 and will run through April 27, 2019. McKesson has experience providing pharmaceuticals, medical supplies, and...
- The Department of Justice Bureau of Prisons awarded a firm fixed price delivery order contract to McKesson Corporation, a healthcare services and information technology company, to provide pharmaceutical products and services to the Federal Medical Center Rochester. The $175,462.83 delivery order was issued against a larger indefinite delivery/indefinite quantity contract vehicle, and no set-aside designation was used. McKesson has received similar orders from other federal agencies, including...
- The Federal Medical Center Rochester, a civilian facility under the Department of Justice, awarded a $5,000 purchase order to McKesson Corporation on December 1, 2025, with an ultimate completion date of December 31, 2025. This firm fixed-price contract represents an open market procurement with no set-aside designation and is being performed at McKesson's location in Irving, Texas. As the nation's largest pharmaceutical distributor and a major supplier of medical products to federal agencies,...
- The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a $3,539.34 firm fixed price purchase order to McKesson Corporation, a healthcare services and information technology company, for the provision of pharmaceutical products and related services. This order is issued under a larger unspecified contract vehicle and does not have a set-aside designation. McKesson has previously provided a range of pharmaceutical items, including HIV medications, specialty drugs, and...
- The Department of Justice Bureau of Prisons awarded a firm fixed price delivery order to McKesson Corporation, a for-profit healthcare services and IT company, to provide medications through the Prime Vendor Program for the Federal Medical Center in Rochester, with an estimated monthly value of $350,000. This delivery order was not set aside for any particular business type. McKesson has received numerous similar awards from federal agencies such as the Department of Veterans Affairs, the Indian...
The Federal Medical Center Rochester, operated by the Department of Justice Bureau of Prisons, awarded a modification to Pantherx Specialty, LLC, a specialty pharmacy headquartered in Pittsburgh, Pennsylvania, resulting in a decrease of $1,144.22 to the contract ceiling value, which now stands at $38,140.38. This firm fixed-price purchase order, issued on January 1, 2026, with an ultimate completion date of January 31, 2026, does not utilize a small business set-aside designation. Pantherx Specialty, a subsidiary of Centene Corporation and registered in the System for Award Management since October 2017, specializes in providing rare disease medications and customized pharmaceutical solutions to federal healthcare agencies, particularly the Department of Veterans Affairs and the Bureau of Prisons. This modification represents a typical adjustment within Pantherx Specialty's established pattern of federal contracting for specialized pharmaceutical procurement. The contractor has consistently delivered difficult-to-source medications—including treatments for immunoglobulin A nephropathy, rare diseases, and emergency pharmaceutical agents—to support critical medical needs within the federal healthcare system. With contract values historically ranging from approximately $10,600 to $85,242, this award falls within the contractor's typical engagement range and reflects the urgent and specialized nature of pharmaceutical supply requirements in federal correctional healthcare settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($1k) | 2/11/26 |